Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90% Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings.
Bausch Health Says Carl Icahn Has 34% Economic Interest In Its Outstanding Shares This disclosure comes days after the company announced a new “poison pill” plan to safeguard shareholders’ rights and prevent hostile takeovers.
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via Phase 3 trials.
Oklo, Quantum Computing And Transocean Are Among Top 10 Mid Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio? Top mid-cap stocks gain, led by energy companies due to increased oil prices from Middle East conflict. Oklo, Bausch Health, Quantum Computing among top performers.
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China.
Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance Bausch Health Companies reported its fourth-quarter results after Wednesday's closing bell. Here's a look at the details from the report:
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb.
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off.
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns.
Bank Of Canada Cuts Rates Again As Inflation, Labor Market Cool: Canadian Stocks Rebound, Loonie Strengthens Bank of Canada cuts key policy rate by 25 basis points to 4.25% and suggests further cuts if inflation continues to ease.
